Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 5Recurrence 2Head and Neck Neoplasms 2Diffuse Intrinsic Pontine Glioma 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence of Head and Cancer in Irraiated Area 1Rectal Neoplasms 1Radiation Injuries 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Diseases 1Nasopharyngeal Carcinoma 1Glioma 1Carcinoma, Squamous Cell 1Breast Cancer Recurrent 1Brain Stem Neoplasms 1Astrocytoma 1

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Re-Irradiation × Clear all
NCT02745847 2023-05-25

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

Changhai Hospital

Phase NA Unknown
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡